Das R N, Chandrashekhar T S, Joshi H S, Gurung M, Shrestha N, Shivananda P G
Department of Medicine, Manipal Teaching Hospital, Manipal College of Medical Sciences, Pokhara, Nepal.
Singapore Med J. 2006 Apr;47(4):281-5.
Urinary tract infection (UTI) is the most common nosocomial infection among hospitalised patients. Area-specific monitoring studies aimed to gain knowledge about the type of pathogens responsible for UTIs and their resistance patterns may help the clinician to choose the correct empirical treatment. Recent reports have shown increasing resistance to commonly-used antibiotics. We aimed to study the antibiotic resistance pattern of the urinary pathogens isolated from hospitalised patients.
Three urine samples were collected by the mid-stream "clean catch" method from 1,680 clinically-suspected cases of urinary tract infections from inpatients of various clinical departments during one year. The samples were tested microbiologically by standard procedures. Antibiotic susceptibility of the isolated pathogens was tested for commonly-used antibiotics by Kirby-Bauer technique according to NCCLS guidelines.
Significant bacteriuria was present in 71.7 percent of the samples, 17 percent were sterile, 4.8 percent showed insignificant bacteriuria, and 6.5 percent non-pathogenic bacteriuria. The most common pathogens isolated were Escherichia coli (59.4 percent), Klebsiella spp (15.7 percent) and Enterococcus faecalis (8.1 percent). The mean susceptibility was high for amikacin (87.2 percent), ciprofloxacin (74.8 percent), ceftazidime (71.5 percent) and gentamicin (70.4 percent) but low for nitrofurantoin (35 percent), cephalexin (49.7 percent) and ampicillin (50.5 percent). Escherichia coli was found to be most susceptible to amikacin (98 percent) followed by gentamicin (87.9 percent), ceftazidime (80.8 percent), norfloxacin (78.4 percent) and cotrimoxazole (77.9 percent).
A high isolation rate of pathogens from urine samples of clinically-suspected UTI shows a good correlation between clinical findings and microbiological methods. The antibiotics commonly used in UTIs are less effective. Since the present study was a cross-sectional study, regular monitoring is required to establish reliable information about resistance pattern of urinary pathogens for optimal empirical therapy of patients with nosocomial UTIs.
尿路感染(UTI)是住院患者中最常见的医院感染。旨在了解导致UTI的病原体类型及其耐药模式的特定区域监测研究,可能有助于临床医生选择正确的经验性治疗方法。最近的报告显示,对常用抗生素的耐药性在增加。我们旨在研究从住院患者中分离出的尿路病原体的抗生素耐药模式。
在一年时间里,通过中段“清洁中段尿”法,从1680例来自各临床科室住院患者的临床疑似尿路感染病例中采集了三份尿液样本。样本按照标准程序进行微生物检测。根据美国国家临床实验室标准委员会(NCCLS)指南,采用 Kirby-Bauer 技术对分离出的病原体进行常用抗生素的药敏试验。
71.7%的样本存在显著菌尿,17%为无菌样本,4.8%显示菌尿不显著,6.5%为非致病性菌尿。分离出的最常见病原体为大肠埃希菌(59.4%)、克雷伯菌属(15.7%)和粪肠球菌(8.1%)。阿米卡星(87.2%)、环丙沙星(74.8%)、头孢他啶(71.5%)和庆大霉素(70.4%)的平均敏感性较高,但呋喃妥因(35%)、头孢氨苄(49.7%)和氨苄西林(50.5%)的敏感性较低。发现大肠埃希菌对阿米卡星最敏感(98%),其次是庆大霉素(87.9%)、头孢他啶(80.8%)、诺氟沙星(78.4%)和复方新诺明(77.9%)。
临床疑似UTI尿液样本中病原体的高分离率表明临床发现与微生物学方法之间具有良好的相关性。UTIs中常用的抗生素效果较差。由于本研究是一项横断面研究,需要定期监测以建立关于尿路病原体耐药模式的可靠信息,以便对医院获得性UTI患者进行最佳经验性治疗。